BTC $64,347.48 -0.38%
ETH $1,803.29 -0.24%
BNB $589.91 -0.17%
XRP $0.9630 +0.67%
SOL $72.84 +1.81%
TRX $0.3054 +0.37%
DOGE $0.0588 -0.02%
ADA $0.1534 +0.65%
BCH $209.32 +1.64%
LINK $9.18 +0.13%
HYPE $68.58 +1.70%
AAVE $111.63 +1.93%
SUI $0.7274 +0.68%
XLM $0.1385 +0.08%
ZEC $936.05 +4.78%
AAPL $352.90 -1.56%
AMZN $257.67 -3.12%
GOOGL $283.20 -4.03%
MSFT $517.13 -2.06%
META $623.69 -2.20%
NVDA $156.78 -1.61%
TSLA $379.05 -2.33%
SNDK $810.76 -3.18%
INTC $54.09 -5.25%
SPCX $137.88 -1.80%
MU $724.57 -2.67%
AMD $510.66 -0.19%
BTC $64,347.48 -0.38%
ETH $1,803.29 -0.24%
BNB $589.91 -0.17%
XRP $0.9630 +0.67%
SOL $72.84 +1.81%
TRX $0.3054 +0.37%
DOGE $0.0588 -0.02%
ADA $0.1534 +0.65%
BCH $209.32 +1.64%
LINK $9.18 +0.13%
HYPE $68.58 +1.70%
AAVE $111.63 +1.93%
SUI $0.7274 +0.68%
XLM $0.1385 +0.08%
ZEC $936.05 +4.78%
AAPL $352.90 -1.56%
AMZN $257.67 -3.12%
GOOGL $283.20 -4.03%
MSFT $517.13 -2.06%
META $623.69 -2.20%
NVDA $156.78 -1.61%
TSLA $379.05 -2.33%
SNDK $810.76 -3.18%
INTC $54.09 -5.25%
SPCX $137.88 -1.80%
MU $724.57 -2.67%
AMD $510.66 -0.19%

Hanyu Pharmaceutical signed a strategic cooperation intention letter with the digital asset platform KuCoin, and the stock price surged to the daily limit

2025-08-04 14:48:33

ChainCatcher news, Hanyu Pharmaceutical (300199.SZ) surged in the afternoon to reach the daily limit, quoted at 24.32 yuan, marking a new high since December 2022.

On the news front, Hanyu Pharmaceutical has officially signed a strategic cooperation intention letter with the digital asset platform KuCoin. The two parties plan to jointly explore the first RWA (Real World Asset) tokenization pilot project in mainland China, based on "future revenue rights of innovative drug research and development" as the underlying asset.

According to the agreement, Hanyu Pharmaceutical will use its technological accumulation and research and development pipeline in the GLP-1 peptide blockbuster drug field as the underlying asset, while KuCoin will leverage its advantages in blockchain technology, RWA full-process solutions, and global compliance resources to provide integrated support for the project, including on-chain mapping, asset tokenization, transaction matching, and revenue distribution. (Gelonghui)

ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click , and we will handle it promptly.

app_icon
ChainCatcher Building the Web3 world with innovations.